Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
SAIHEAT Announces The Upcoming 2024 BIT HEAT DAY
-
Markforged Sets Reporting Date for Third Quarter 2024 Financial Results
-
OMNIQ Secures $1.4 Million Contract Renewal with Leading Transportation & Logistics Giant
-
Safe & Green Holdings Corp. Announces Successful Completion of Two Major Projects for U.S. Government Contractor
-
Eterna Therapeutics Completes Strategic Financial Restructuring with the Aim to Accelerate its Developmental Activities and Long-Term Success
-
SAIHEAT Announces The Upcoming 2024 BIT HEAT DAY
-
Tiziana Life Sciences Announces Positive Results from Ozempic and Nasal Anti-CD3 Combination Study
-
HeartCore Expands its CMS Platform Offering into a SaaS Delivery Model
-
Allogene Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update
-
AI Company Brand Engagement Network Announces Agreement to Acquire German Media Technology Leader Cataneo Gmbh
-
Yoshiharu Announces Grand Opening of New San Clemente, CA Location on Thursday, October 31
-
Safe & Green Holdings Corp. Announces Successful Completion of Two Major Projects for U.S. Government Contractor
-
Autonomix Medical, Inc.’s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical Trial
-
AgEagle Aerial Systems Announces Appointment of Kevin Lowdermilk to Board of Directors
-
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
-
CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories
-
Sow Good Inc. Builds on Steady Innovation Pipeline with Variety of New and Unique Freeze-Dried Candies
-
Vireo Growth Inc. to Release Third Quarter 2024 Results on November 13, 2024
-
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
-
Recursion to Report Third Quarter 2024 Business Updates and Financial Results on November 6th
-
Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain
-
LED Lighting, EV Charging Solutions and Maintenance Solutions Provider Orion Energy Systems Hosts Q2 Call Wed., Nov. 6th at 10am ET
-
Bling One Seasons, Bling One Peru, and China’s Debut Showcase the Potential of Click the Star, a Global Audition Across 32 Countries
-
ES Bancshares, Inc. Announces Third Quarter 2024 Results; Continues Trend of Net Interest Margin Expansion and Revenue Growth
-
Celestica Announces TSX Acceptance of Early Renewal of Its Normal Course Issuer Bid
-
HII Increases Quarterly Dividend to $1.35 per Share
-
Freddie Mac Announces Third Quarter 2024 Financial Results
-
DatChat Subsidiary Dragon Interact Acquires RPM Interactive, a Start-Up AI Publishing Company
-
Preferred Hotels & Resorts Expands Global Portfolio with 24 New Member Properties
-
Preferred Hotels & Resorts Expands Global Portfolio with 24 New Member Properties
-
Bybit to Host Exclusive Forum: Bridging Islamic Finance and Cryptocurrency
-
Asante Announces $525 Million Financing Package
-
Boba Mint Holdings Announces Major Milestones for Blockchain Game Tanjea Amidst Surging User Growth
-
A Race Against Blindness Grants $1 Million Supporting Axovia Therapeutics’ Planned Clinical Trial for Bardet-Biedl Syndrome (BBS)
-
Form 8.3 - Learning Technologies Group Plc
-
Meritage Homes Announces Entry into the Gulf Coast Markets with Acquisition of the Assets of Elliott Homes
-
Madrigal Pharmaceuticals to Present Multiple Rezdiffra™ (resmetirom) Abstracts in NASH/MASH at the AASLD Liver Meeting®
-
Capital Power announces third quarter 2024 results
-
94% of Canadians expect holiday spending to cause financial stress
-
Employee wellbeing is a human right: Workplace values index
-
ITW Reports Third Quarter 2024 Results
-
Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024
-
COUR Pharmaceuticals Doses First Patient in Phase 1b/2a Clinical Trial Evaluating CNP-106 in Generalized Myasthenia Gravis
-
IQST - iQSTEL to Present at the AI & Technology Virtual Investor Conference October 31st
-
ConnectWise’s Asio Platform Recognized as CRN 2024 Product of the Year Finalist
-
Canadian AI job market shifting, favouring specialized, in-demand skills
-
Two Six Technologies Captures Strategic Win with Award on $4 Billion DTRA Contract
-
Mineralys Therapeutics Completes Enrollment Ahead of Schedule in Launch-HTN, the Second Pivotal Trial of Lorundrostat for the Treatment of Hypertension
-
Alignment Health Plan Named a “Best” Medicare Advantage Insurer in North Carolina by U.S. News & World Report for Third Consecutive Year
-
Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3

